Total and phosphorylated IκBα protein levels were measured by Western blot in non-tumor bearing epidermis and tumors; it was found that PDTC treatment specifically abrogated increases in phophorylated IκBα in non-tumor bearing skin suggesting a functional blockade of the NFκB signaling pathway (Figure S3C). The gene discussed is NFKB1; the disease is neoplasm.